Literature DB >> 11440372

Analysis of the lamin A/C gene as a candidate for type II diabetes susceptibility in Pima Indians.

J K Wolford1, R L Hanson, C Bogardus, M Prochazka.   

Abstract

AIMS/HYPOTHESIS: Lamin A/C (LMNA) is located within a region on chromosome 1q that has been linked with Type II (non-insulin-dependent) diabetes mellitus in Pima Indians. Rare mutations in exon 8 of LMNA underlie Dunnigan-Type familial partial lipodystrophy, a disease characterized by regional adipocyte degeneration and frequently accompanied by insulin resistance, glucose intolerance, and diabetes. A more common variant in exon 10 (3408C/T) has recently been associated with obesity in non-diabetic aboriginal Canadian subjects. Because obesity is a strongly predisposing factor for Type II diabetes, we hypothesized that the LMNA 3408C/T variant could be associated with diabetes and body mass index in Pima Indians.
METHODS: To determine whether the LMNA 3408C/T variant contributes to Type II diabetes susceptibility, we genotyped the polymorphism in 1,338 Pimas using allelic discrimination technology. The locus was screened for additional variants in 20 diabetic Pima Indians and non-diabetic Pima Indians using denaturing high performance liquid chromatography and dideoxy sequencing.
RESULTS: We found no evidence for association of 3408C/T with diabetes, body mass index, total cholesterol, HDL cholesterol, triglycerides, leptin concentrations, or indices of insulin sensitivity and secretion. Subsequent screening of the remaining LMNA exons and flanking sequences revealed only rare variants in intron 4 and the 3'UTR, showing no frequency differences between diabetic and non-diabetic Pima Indians. We reassessed the linkage with diabetes following adjustment for the LMNA 3408C/T variant; adjustment for the effects of LMNA did not substantially modify the evidence for linkage. CONCLUSION/
INTERPRETATION: We conclude that the LMNA 3408C/T variant probably does not play a role in susceptibility to diabetes or obesity in Pima Indians.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440372     DOI: 10.1007/s001250051688

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

1.  Evaluating the association of common LMNA variants with type 2 diabetes and quantitative metabolic phenotypes in French Europids.

Authors:  K Duesing; G Charpentier; M Marre; J Tichet; S Hercberg; P Froguel; F Gibson
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

2.  Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

Authors:  M Lundgren; M Svensson; S Lindmark; F Renström; T Ruge; J W Eriksson
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

3.  The Val81 missense mutation of the melanocortin 3 receptor gene, but not the 1908c/T nucleotide polymorphism in lamin A/C gene, is associated with hyperleptinemia and hyperinsulinemia in obese Greek caucasians.

Authors:  N Yiannakouris; L Melistas; M Kontogianni; K Heist; C S Mantzoros
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

4.  Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study.

Authors:  Benedicte Fontaine-Bisson; Marie-Christine Alessi; Noemie Saut; Frederic Fumeron; Michel Marre; Anne Dutour; Catherine Badens; Nicolas Levy; Jean Tichet; Irene Juhan-Vague; David-Alexandre Trégouët; Beverly Balkau; Pierre-Emmanuel Morange
Journal:  J Mol Med (Berl)       Date:  2009-10-16       Impact factor: 4.599

5.  Lamin A/C polymorphisms, type 2 diabetes, and the metabolic syndrome: case-control and quantitative trait studies.

Authors:  José L Mesa; Ruth J F Loos; Paul W Franks; Ken K Ong; Jian'an Luan; Stephen O'Rahilly; Nicholas J Wareham; Inês Barroso
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

6.  Common variation in the LMNA gene (encoding lamin A/C) and type 2 diabetes: association analyses in 9,518 subjects.

Authors:  Katharine R Owen; Christopher J Groves; Robert L Hanson; William C Knowler; Alan R Shuldiner; Steven C Elbein; Braxton D Mitchell; Philippe Froguel; Maggie C Y Ng; Juliana C Chan; Weiping Jia; Panos Deloukas; Graham A Hitman; Mark Walker; Timothy M Frayling; Andrew T Hattersley; Eleftheria Zeggini; Mark I McCarthy
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

Review 7.  Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases.

Authors:  Alex Zhavoronkov; Zeljka Smit-McBride; Kieran J Guinan; Maria Litovchenko; Alexey Moskalev
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

Review 8.  The search for type 2 diabetes susceptibility loci: the chromosome 1q story.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Curr Diab Rep       Date:  2007-04       Impact factor: 5.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.